Annual Working Capital
$592.30 M
+$281.29 M+90.44%
September 30, 2024
Summary
- As of February 7, 2025, ARWR annual working capital is $592.30 million, with the most recent change of +$281.29 million (+90.44%) on September 30, 2024.
- During the last 3 years, ARWR annual working capital has risen by +$354.24 million (+148.80%).
- ARWR annual working capital is now at all-time high.
Performance
ARWR Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$592.30 M
+$238.96 M+67.63%
September 30, 2024
Summary
- As of February 7, 2025, ARWR quarterly working capital is $592.30 million, with the most recent change of +$238.96 million (+67.63%) on September 30, 2024.
- Over the past year, ARWR quarterly working capital has increased by +$115.83 million (+24.31%).
- ARWR quarterly working capital is now at all-time high.
Performance
ARWR Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ARWR Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.4% | +24.3% |
| 3 y3 years | +148.8% | +148.8% |
| 5 y5 years | +252.2% | +148.8% |
ARWR Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +148.8% | at high | +240.1% |
| 5 y | 5-year | at high | +252.2% | at high | +240.1% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Arrowhead Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | $592.30 M(+90.4%) | $592.30 M(+67.6%) |
| Jun 2024 | - | $353.35 M(-25.8%) |
| Mar 2024 | - | $476.48 M(+173.6%) |
| Dec 2023 | - | $174.18 M(-44.0%) |
| Sep 2023 | $311.02 M(+16.7%) | $311.02 M(-22.2%) |
| Jun 2023 | - | $399.94 M(-18.0%) |
| Mar 2023 | - | $487.66 M(+7.7%) |
| Dec 2022 | - | $452.99 M(+70.0%) |
| Sep 2022 | $266.45 M(+11.9%) | $266.45 M(-12.4%) |
| Jun 2022 | - | $304.18 M(+9.1%) |
| Mar 2022 | - | $278.77 M(+38.5%) |
| Dec 2021 | - | $201.25 M(-15.5%) |
| Sep 2021 | $238.06 M(-15.5%) | $238.06 M(-28.0%) |
| Jun 2021 | - | $330.52 M(-21.2%) |
| Mar 2021 | - | $419.57 M(+40.5%) |
| Dec 2020 | - | $298.62 M(+6.0%) |
| Sep 2020 | $281.69 M(+67.5%) | $281.69 M(+3.4%) |
| Jun 2020 | - | $272.45 M(+4.3%) |
| Mar 2020 | - | $261.14 M(-39.8%) |
| Dec 2019 | - | $433.92 M(+158.0%) |
| Sep 2019 | $168.18 M(+153.3%) | $168.18 M(+6.8%) |
| Jun 2019 | - | $157.45 M(+18.2%) |
| Mar 2019 | - | $133.16 M(+16.5%) |
| Dec 2018 | - | $114.34 M(+72.2%) |
| Sep 2018 | $66.40 M(+35.0%) | $66.40 M(+21.3%) |
| Jun 2018 | - | $54.74 M(-34.5%) |
| Mar 2018 | - | $83.54 M(+112.1%) |
| Dec 2017 | - | $39.39 M(-19.9%) |
| Sep 2017 | $49.20 M(-24.1%) | $49.20 M(-14.6%) |
| Jun 2017 | - | $57.58 M(-7.3%) |
| Mar 2017 | - | $62.14 M(-10.2%) |
| Dec 2016 | - | $69.23 M(+6.7%) |
| Sep 2016 | $64.86 M(-25.4%) | $64.86 M(+86.6%) |
| Jun 2016 | - | $34.76 M(-33.3%) |
| Mar 2016 | - | $52.09 M(-25.5%) |
| Dec 2015 | - | $69.96 M(-19.6%) |
| Sep 2015 | $86.97 M(-39.2%) | $86.97 M(-17.3%) |
| Jun 2015 | - | $105.16 M(-1.7%) |
| Mar 2015 | - | $106.94 M(-11.4%) |
| Dec 2014 | - | $120.67 M(-15.6%) |
| Sep 2014 | $142.95 M(+610.6%) | $142.95 M(-7.9%) |
| Jun 2014 | - | $155.17 M(+2.5%) |
| Mar 2014 | - | $151.44 M(+124.7%) |
| Dec 2013 | - | $67.39 M(+235.0%) |
| Sep 2013 | $20.12 M(+1523.3%) | $20.12 M(-27.5%) |
| Jun 2013 | - | $27.73 M(-909.9%) |
| Mar 2013 | - | -$3.42 M(>+9900.0%) |
| Dec 2012 | - | -$14.00 K(-101.1%) |
| Sep 2012 | $1.24 M | $1.24 M(+1314.8%) |
| Jun 2012 | - | $87.60 K(-96.4%) |
| Mar 2012 | - | $2.44 M(-40.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | - | $4.11 M(-43.5%) |
| Sep 2011 | $7.28 M(+88.8%) | $7.28 M(+48.9%) |
| Jun 2011 | - | $4.89 M(-19.7%) |
| Mar 2011 | - | $6.09 M(+93.9%) |
| Dec 2010 | - | $3.14 M(-18.6%) |
| Sep 2010 | $3.86 M(+2667.8%) | $3.86 M(-22.7%) |
| Jun 2010 | - | $4.99 M(+601.4%) |
| Mar 2010 | - | $710.80 K(-54.7%) |
| Dec 2009 | - | $1.57 M(+1026.1%) |
| Sep 2009 | $139.30 K(-98.0%) | $139.30 K(-121.3%) |
| Jun 2009 | - | -$655.00 K(+141.5%) |
| Mar 2009 | - | -$271.20 K(-106.5%) |
| Dec 2008 | - | $4.16 M(-39.1%) |
| Sep 2008 | $6.83 M(-69.5%) | $6.83 M(-43.0%) |
| Jun 2008 | - | $11.99 M(-34.3%) |
| Mar 2008 | - | $18.25 M(-23.7%) |
| Dec 2007 | - | $23.92 M(+6.8%) |
| Sep 2007 | $22.41 M(-13.3%) | $22.41 M(-23.2%) |
| Jun 2007 | - | $29.17 M(+36.6%) |
| Mar 2007 | - | $21.35 M(-23.2%) |
| Dec 2006 | - | $27.79 M(+7.5%) |
| Sep 2006 | $25.86 M(+18.7%) | $25.86 M(-12.7%) |
| Jun 2006 | - | $29.61 M(-11.7%) |
| Mar 2006 | - | $33.52 M(+85.6%) |
| Dec 2005 | - | $18.06 M(-17.1%) |
| Sep 2005 | $21.79 M(+147.4%) | $21.79 M(-11.7%) |
| Jun 2005 | - | $24.67 M(+170.4%) |
| Mar 2005 | - | $9.12 M(+31.0%) |
| Dec 2004 | - | $6.96 M(-21.0%) |
| Sep 2004 | $8.81 M(+521.2%) | $8.81 M(-16.6%) |
| Jun 2004 | - | $10.56 M(-7.8%) |
| Mar 2004 | - | $11.46 M(+444.3%) |
| Dec 2003 | - | $2.11 M(+48.5%) |
| Sep 2003 | $1.42 M(-191.2%) | $1.42 M(-180.9%) |
| Jun 2003 | - | -$1.75 M(+3.0%) |
| Mar 2003 | - | -$1.70 M(+6.4%) |
| Dec 2002 | - | -$1.60 M(+2.9%) |
| Sep 2002 | -$1.55 M(+22.2%) | -$1.55 M(+5.6%) |
| Jun 2002 | - | -$1.47 M(+9.1%) |
| Mar 2002 | - | -$1.35 M(+1.0%) |
| Dec 2001 | - | -$1.34 M(+5.0%) |
| Sep 2001 | -$1.27 M(+11.6%) | -$1.27 M(+5.2%) |
| Jun 2001 | - | -$1.21 M(+2.9%) |
| Mar 2001 | - | -$1.17 M(+0.5%) |
| Dec 2000 | - | -$1.17 M(+2.6%) |
| Sep 2000 | -$1.14 M(+12.9%) | -$1.14 M(-3.0%) |
| Jun 2000 | - | -$1.17 M(+4.8%) |
| Mar 2000 | - | -$1.12 M(+4.8%) |
| Dec 1999 | - | -$1.07 M |
| Sep 1999 | -$1.01 M(-64.2%) | - |
| Sep 1998 | -$2.82 M(+6.3%) | - |
| Sep 1997 | -$2.65 M | - |
FAQ
- What is Arrowhead Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals annual working capital year-on-year change?
- What is Arrowhead Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Arrowhead Pharmaceuticals?
- What is Arrowhead Pharmaceuticals quarterly working capital year-on-year change?
What is Arrowhead Pharmaceuticals annual working capital?
The current annual working capital of ARWR is $592.30 M
What is the all time high annual working capital for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high annual working capital is $592.30 M
What is Arrowhead Pharmaceuticals annual working capital year-on-year change?
Over the past year, ARWR annual working capital has changed by +$281.29 M (+90.44%)
What is Arrowhead Pharmaceuticals quarterly working capital?
The current quarterly working capital of ARWR is $592.30 M
What is the all time high quarterly working capital for Arrowhead Pharmaceuticals?
Arrowhead Pharmaceuticals all-time high quarterly working capital is $592.30 M
What is Arrowhead Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, ARWR quarterly working capital has changed by +$115.83 M (+24.31%)